The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kinnate Biopharma Inc(NASDAQ:KNTE) 
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. It develops KIN-2787, which is a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma...
Website: https://www.kinnate.com/
Founded: 2018
CEO: Nima Farzan
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Kinnate Biopharma Days Payable Outstanding ttm (DPO)
Kinnate Biopharma Op Cashflow Per Share ttm
Kinnate Biopharma Free Cashflow Per Share ttm
Kinnate Biopharma Cash Per Share ttm
Kinnate Biopharma (GAAP) P/E ratio ttm
Kinnate Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.